⚖️ Bioethics, Biopatents & Biopiracy
Learn bioethics, biopiracy and IPR in biotechnology for CUET Agriculture. Neem-turmeric cases, Biological Diversity Act and GM crop debates.
Bioethics
As biotechnology's power to manipulate living organisms increases, so does the responsibility to use it wisely. Bioethics addresses the moral and ethical implications of biotechnology applications.
Key Ethical Issues
| Issue | Description |
|---|---|
| GMO safety | Are genetically modified organisms safe for human consumption and the environment long-term? |
| Allergenicity | Can transgenic proteins cause allergic reactions (e.g., Brazil nut protein in soybean — abandoned)? |
| Antibiotic resistance transfer | Could antibiotic resistance marker genes transfer from GM plants to gut bacteria? |
| Gene flow | Can transgenes spread from GM crops to wild relatives through cross-pollination (genetic contamination of natural populations)? |
| Bioweapons | Potential misuse of rDNA technology to create biological warfare agents. |
| Human cloning | Ethical concerns about reproductive cloning of humans. |
| Germline gene therapy | Should we modify genes that will be inherited by all future generations? |
| Animal rights | Ethical treatment of transgenic animals used in research. |
| Socioeconomic issues | Corporate control of seeds and food supply (proprietary seeds); impact on small farmers in developing countries. |
| Playing God | Concerns about the hubris of radically altering life forms. |
Biopatents
What is a Patent?
- Patent = Legal protection granting the inventor exclusive rights to their invention for a limited period (usually 20 years).
- Prevents others from making, using, or selling the invention without permission.
- After expiry: invention enters public domain.
Biopatents
- Biopatent — patent on biological material (genes, organisms, cell lines, biotechnological processes).
- Extremely controversial: Should living organisms or naturally occurring genes be owned?
Landmark Case: Diamond v. Chakrabarty (1980)
- Ananda Mohan Chakrabarty (1971) — Indian-American scientist at General Electric; engineered Pseudomonas putida ("superbug") that could degrade multiple petroleum hydrocarbons simultaneously. Natural Pseudomonas strains can each only degrade one hydrocarbon; Chakrabarty combined the degradative plasmids into one bacterium.
- Applied for a patent on this genetically engineered bacterium.
- US Supreme Court ruled 5-4 (1980): A living, genetically modified organism can be patented — "anything under the sun that is made by man" is patentable subject matter.
- This was the first organism to be patented — a landmark decision that opened the door to the entire biotechnology patent industry.
NOTE
🔐
Pro Content Locked
Upgrade to Pro to access this lesson and all other premium content.
Pro
Popular Save ₹100/mo
₹ 99 /mo
₹99 charged monthly · Cancel anytime
- All Agriculture & Banking Courses
- AI Lesson Questions (100/day)
- AI Doubt Solver (50/day)
- Glows & Grows Feedback (30/day)
- AI Section Quiz (20/day)
- 22-Language Translation (100/day)
- Recall Questions (20/day)
- AI Quiz (15/day)
- AI Quiz Paper Analysis (100/day)
- AI Step-by-Step Explanations (100/day)
- Spaced Repetition Recall (FSRS)
- AI Tutor
- Immersive Text Questions
- Audio Lessons — Hindi & English
- Mock Tests & Previous Year Papers
- Summary & Mind Maps
- XP, Levels, Leaderboard & Badges
- Generate New Classrooms
- Voice AI Teacher (AgriDots Live)
- AI Revision Assistant
- Knowledge Gap Analysis
- Interactive Revision (LangGraph)
🔒 Secure via Razorpay · Cancel anytime · No hidden fees
Bioethics
As biotechnology's power to manipulate living organisms increases, so does the responsibility to use it wisely. Bioethics addresses the moral and ethical implications of biotechnology applications.
Key Ethical Issues
| Issue | Description |
|---|---|
| GMO safety | Are genetically modified organisms safe for human consumption and the environment long-term? |
| Allergenicity | Can transgenic proteins cause allergic reactions (e.g., Brazil nut protein in soybean — abandoned)? |
| Antibiotic resistance transfer | Could antibiotic resistance marker genes transfer from GM plants to gut bacteria? |
| Gene flow | Can transgenes spread from GM crops to wild relatives through cross-pollination (genetic contamination of natural populations)? |
| Bioweapons | Potential misuse of rDNA technology to create biological warfare agents. |
| Human cloning | Ethical concerns about reproductive cloning of humans. |
| Germline gene therapy | Should we modify genes that will be inherited by all future generations? |
| Animal rights | Ethical treatment of transgenic animals used in research. |
| Socioeconomic issues | Corporate control of seeds and food supply (proprietary seeds); impact on small farmers in developing countries. |
| Playing God | Concerns about the hubris of radically altering life forms. |
Biopatents
What is a Patent?
- Patent = Legal protection granting the inventor exclusive rights to their invention for a limited period (usually 20 years).
- Prevents others from making, using, or selling the invention without permission.
- After expiry: invention enters public domain.
Biopatents
- Biopatent — patent on biological material (genes, organisms, cell lines, biotechnological processes).
- Extremely controversial: Should living organisms or naturally occurring genes be owned?
Landmark Case: Diamond v. Chakrabarty (1980)
- Ananda Mohan Chakrabarty (1971) — Indian-American scientist at General Electric; engineered Pseudomonas putida ("superbug") that could degrade multiple petroleum hydrocarbons simultaneously. Natural Pseudomonas strains can each only degrade one hydrocarbon; Chakrabarty combined the degradative plasmids into one bacterium.
- Applied for a patent on this genetically engineered bacterium.
- US Supreme Court ruled 5-4 (1980): A living, genetically modified organism can be patented — "anything under the sun that is made by man" is patentable subject matter.
- This was the first organism to be patented — a landmark decision that opened the door to the entire biotechnology patent industry.
NOTE
In contrast, in 2013 the US Supreme Court ruled (Association for Molecular Pathology v. Myriad Genetics) that naturally occurring DNA sequences cannot be patented, but synthetic cDNA (which does not occur naturally) can be patented.
Biopiracy
Definition
Biopiracy = The unauthorized use or exploitation of biological resources and traditional knowledge of indigenous communities by corporations or organizations, often for patent purposes, without fair compensation or acknowledgment.
India has been a major target of biopiracy due to its rich biodiversity and ancient traditional knowledge systems (Ayurveda, Unani, Siddha, Yoga).
Major Biopiracy Cases
| Case | Details | Outcome |
|---|---|---|
| Turmeric Patent (1995) | US Patent and Trademark Office granted patent on turmeric for wound healing to University of Mississippi Medical Center. Turmeric (Curcuma longa) has been used in India for wound healing for centuries. India's CSIR challenged. | Patent revoked (1997) — first successful biopiracy challenge by India. Prior art (ancient Indian texts) used as evidence. |
| Neem Patent | European Patent Office granted patent to W.R. Grace Company (USA) on neem-based biopesticide (azadirachtin extraction). Neem has been used in India for centuries as pesticide and medicine. | Patent revoked (2005) after challenge by India, Greenpeace, and the International Federation of Organic Agriculture Movements (IFOAM). |
| Basmati Rice Patent (1997) | RiceTec Inc. (USA) obtained a US patent on Basmati rice lines and grain. Basmati is a traditional variety from India and Pakistan. India challenged — Basmati is a geographical indication product. | Most patent claims were revoked; some narrow claims allowed. India secured geographical indication for Basmati. |
| Bt Brinjal | Mahyco-Monsanto used local Indian brinjal varieties to develop Bt Brinjal without proper authorization → raised biopiracy concerns regarding local germplasm. | Moratorium imposed in India (2010). |
India's Response to Biopiracy
India has taken several legislative and institutional measures to protect its biological resources and traditional knowledge.
1. Traditional Knowledge Digital Library (TKDL)
- TKDL — pioneering Indian initiative that documents traditional knowledge related to Ayurveda, Unani, Siddha, and Yoga in a searchable, structured format.
- Contains information on about 2.9 lakh formulations from Indian traditional medicine systems.
- Translated into English, French, German, Spanish, and Japanese.
- Accessible to international patent offices as prior art evidence — when a patent application is filed claiming an "invention" that is actually traditional knowledge, examiners can search TKDL to reject it.
- Has successfully helped defeat 200+ wrongful patent applications worldwide.
2. Biological Diversity Act (2002)
- Biological Diversity Act, 2002 — India.
- Regulates access to biological resources and associated traditional knowledge.
- Requires prior approval (Biodiversity Management Committees) for access by foreign entities.
- Established the National Biodiversity Authority (NBA) — headquartered in Chennai.
3. Protection of Plant Varieties and Farmers' Rights Act (PPV&FR Act, 2001)
- PPV&FR Act, 2001 — India.
- Protects plant breeders' rights (commercial plant variety protection) AND farmers' rights — unique globally for explicitly recognizing farmers' contributions.
- Farmers can save, use, resow, and exchange seeds of protected varieties (but not sell them commercially).
- Established the Protection of Plant Varieties and Farmers' Rights Authority (PPVFRA).
4. Convention on Biological Diversity (CBD)
- International treaty (CBD, 1992 — Rio Earth Summit) that established:
- Sovereign rights of countries over their biological resources.
- Fair and equitable sharing of benefits arising from the use of genetic resources.
- Prior Informed Consent (PIC) required before accessing another country's biological resources.
- Nagoya Protocol (2010) — operationalized the access and benefit sharing (ABS) provisions of the CBD.
Key Legislations and Bodies
| Legislation / Body | Year | Purpose |
|---|---|---|
| Diamond v. Chakrabarty | 1980 | First living organism patented (US); opened biotech patent era |
| Convention on Biological Diversity (CBD) | 1992 | Sovereign rights over biodiversity; benefit sharing |
| PPV&FR Act | 2001 | Plant variety protection + farmers' rights (India) |
| Biological Diversity Act | 2002 | Regulates access to biological resources (India) |
| TKDL | 2001 (established) | Digital library of traditional knowledge as prior art against biopiracy |
| NBA (National Biodiversity Authority) | 2003 | Implements Biological Diversity Act; headquarters Chennai |
| Nagoya Protocol | 2010 | Access and benefit sharing under CBD |
Key Points to Remember
- Bioethics issues: GMO safety, allergenicity, antibiotic resistance transfer, gene flow, bioweapons, germline therapy, animal rights, corporate control of seeds.
- Biopatent: 20 years protection; applies to GM organisms, processes, gene sequences (not naturally occurring).
- Chakrabarty's Pseudomonas putida (1971): oil-degrading; Diamond v. Chakrabarty (1980): first patented organism; 5-4 Supreme Court decision.
- Biopiracy = unauthorized exploitation of biodiversity/traditional knowledge without fair compensation.
- Turmeric patent (1995, revoked 1997) — India's CSIR; first successful biopiracy challenge.
- Neem patent revoked 2005; Basmati — most claims revoked.
- TKDL — 2.9 lakh formulations; prior art against biopiracy.
- Biological Diversity Act (2002) + NBA (Chennai) — regulate biological resource access.
- PPV&FR Act (2001) — plant variety protection + farmers' rights.
- CBD (1992) — sovereign rights over biodiversity; Nagoya Protocol (2010) — ABS mechanism.
Summary Cheat Sheet
| Concept / Topic | Key Details / Explanation |
|---|---|
| Bioethics | Addresses moral and ethical implications of biotechnology applications |
| Key bioethics issues | GMO safety, allergenicity, antibiotic resistance transfer, gene flow to wild relatives, bioweapons, human cloning, germline gene therapy, animal rights, corporate seed control |
| Allergenicity example | Brazil nut protein in soybean — abandoned due to allergy risk |
| Patent (definition) | Legal protection granting inventor exclusive rights for 20 years; after expiry enters public domain |
| Biopatent | Patent on biological material — genes, organisms, cell lines, biotechnological processes |
| Diamond v. Chakrabarty (1980) | US Supreme Court ruled 5-4: a living, genetically modified organism can be patented — "anything under the sun made by man" |
| Chakrabarty's organism | Ananda Mohan Chakrabarty (1971) engineered Pseudomonas putida to degrade multiple petroleum hydrocarbons simultaneously; first organism to be patented |
| Myriad Genetics ruling (2013) | Naturally occurring DNA sequences cannot be patented, but synthetic cDNA can be patented |
| Biopiracy (definition) | Unauthorized exploitation of biological resources and traditional knowledge of indigenous communities without fair compensation |
| Turmeric patent (1995) | US patent on turmeric for wound healing to Univ. of Mississippi; India's CSIR challenged; patent revoked (1997) — first successful biopiracy challenge by India |
| Neem patent | European patent to W.R. Grace Company on neem biopesticide; revoked (2005) after challenge by India, Greenpeace, IFOAM |
| Basmati rice patent (1997) | RiceTec Inc. (USA) patented Basmati lines; most claims revoked; India secured geographical indication for Basmati |
| Bt Brinjal biopiracy concern | Mahyco-Monsanto used local Indian brinjal varieties without proper authorization; moratorium imposed in India (2010) |
| TKDL | Traditional Knowledge Digital Library — documents ~2.9 lakh formulations from Ayurveda, Unani, Siddha, Yoga; translated into 5 languages; helps defeat 200+ wrongful patent applications worldwide |
| Biological Diversity Act | 2002, India; regulates access to biological resources; requires prior approval from Biodiversity Management Committees for foreign access |
| NBA | National Biodiversity Authority; headquartered in Chennai; implements Biological Diversity Act |
| PPV&FR Act | 2001, India; protects plant breeders' rights AND farmers' rights (unique globally); farmers can save, use, resow, exchange seeds but not sell commercially |
| PPVFRA | Protection of Plant Varieties and Farmers' Rights Authority — established under PPV&FR Act |
| CBD | Convention on Biological Diversity (1992) — Rio Earth Summit; established sovereign rights over biological resources, fair benefit sharing, Prior Informed Consent (PIC) |
| Nagoya Protocol | 2010; operationalized Access and Benefit Sharing (ABS) provisions of the CBD |
Lesson Doubts
Ask questions, get expert answers